Paul Sekhri, new CEO of vTv Therapeutics, touts potential for diabetes drug as he looks to turn biotech around


"My focus is to turn the company around and get it back on track," said Paul Sekhri, the new CEO of vTv Therapeutics.

Previous Wells Fargo, Bank of America and Truist among banks watching closely as Biden, CFPB attack 'junk' fees
Next Winston-Salem City Council rezones site for controversial 231-home development